No spreading of immune response against glutamic acid decarboxylase in latent autoimmune diabetes

被引：0
|
作者：
Ziegler, B
Rjasanowski, I
Strebelow, M
Schlosser, M
Powers, AC
Ziegler, M
机构：
[1] INST DIABET ENDOCRINOL & METAB DIS,KARLSBURG,GERMANY
[2] UNIV GREIFSWALD,CLINICUM KARLSBURG,D-2200 GREIFSWALD,GERMANY
[3] VANDERBILT UNIV,NASHVILLE,TN
来源：
DIABETOLOGIA | 1996年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [21] CYTOTOXIC T-CELLS SPECIFIC FOR GLUTAMIC-ACID DECARBOXYLASE IN AUTOIMMUNE DIABETES
    PANINABORDIGNON, P
    LANG, R
    VANENDERT, PM
    BENAZZI, E
    FELIX, AM
    PASTORE, RM
    SPINAS, GA
    SINIGAGLIA, F
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) : 1923 - 1927
  • [22] Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus
    Villalba, Anabel
    Iacono, Ruben F.
    Valdez, Silvina N.
    Poskus, Edgardo
    AUTOIMMUNITY, 2008, 41 (02) : 143 - 153
  • [23] Immunotherapy of Autoimmune Diabetes by Nasal Administration of Tandem Glutamic Acid Decarboxylase 65 Peptides
    Wang, Huaqian
    Yang, Jie
    Jin, Liang
    Feng, Jiao
    Lu, Yong
    Sun, Yunxiao
    Li, Taiming
    Cao, Rongyue
    Wu, Jie
    Fan, Hao
    Liu, Jingjing
    IMMUNOLOGICAL INVESTIGATIONS, 2009, 38 (08) : 690 - 703
  • [24] LATENT AUTOIMMUNE DIABETES-MELLITUS IN ADULTS (LADA) - THE ROLE OF ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE IN DIAGNOSIS AND PREDICTION OF INSULIN DEPENDENCY
    ZIMMET, PZ
    TUOMI, T
    MACKAY, JR
    ROWLEY, MJ
    KNOWLES, W
    COHEN, M
    LANG, DA
    DIABETIC MEDICINE, 1994, 11 (03) : 299 - 303
  • [25] Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)
    Lohmann, T
    Kellner, K
    Verlohren, HJ
    Krug, J
    Steindorf, J
    Scherbaum, WA
    Seissler, J
    DIABETOLOGIA, 2001, 44 (08) : 1005 - 1010
  • [26] Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)
    T. Lohmann
    K. Kellner
    H.-J. Verlohren
    J. Krug
    J. Steindorf
    W. A. Scherbaum
    J. Seissler
    Diabetologia, 2001, 44 : 1005 - 1010
  • [27] Autoantibodies against glutamic acid decarboxylase and 21-hydroxylase in Brazilian patients with Type 1 diabetes or autoimmune thyroid diseases
    Silva, RC
    Sallorenzo, C
    Kater, CE
    Dib, SA
    Falorni, A
    DIABETES NUTRITION & METABOLISM, 2003, 16 (03) : 160 - 168
  • [28] Correlation between the prevalence of type 1 diabetes with the daily insulin dose and the autoimmune process against glutamic acid decarboxylase in adults
    Khalangot, M.
    Kravchenko, V.
    Tronko, M.
    Gur'ianov, V.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (06) : 611 - 615
  • [29] The potential of anti-glutamic acid decarboxylase antibodies to support a diagnosis of autoimmune diabetes mellitus
    Liepert, Maryah
    Alhaqqan, Shamayel
    Husain, Alaa
    Lochnan, Heather
    Booth, Ronald A.
    Shaw, Julie
    Sun, Cathy J.
    CLINICAL BIOCHEMISTRY, 2025, 135
  • [30] Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
    Clark, A
    Desai, M
    Cull, CA
    Horton, VA
    Christie, MR
    Bingley, PJ
    Bonifacio, E
    Levy, JC
    Holman, RR
    DIABETOLOGIA, 2005, 48 : A86 - A87
12345